FDAnews
www.fdanews.com/articles/122254-fda-roche-novartis-asthma-drug-effect-modest

FDA: Roche/Novartis Asthma Drug Effect Modest

November 16, 2009
An asthma drug from Roche and Novartis has ‘somewhat modest’ benefits for kids aged 6 to 11, U.S. reviewers said in documents.
Forbes